UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (6954) 6954
Journal Article (3737) 3737
Conference Proceeding (194) 194
Book Chapter (23) 23
Dissertation (5) 5
Book / eBook (4) 4
Magazine Article (4) 4
Report (4) 4
Newspaper Article (3) 3
Technical Report (3) 3
Journal / eJournal (2) 2
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
electricity (3368) 3368
physics (2950) 2950
electric communication technique (2363) 2363
pictorial communication, e.g. television (2161) 2161
science & technology (1632) 1632
performing operations (1581) 1581
transporting (1581) 1581
chemistry (1565) 1565
counting (1498) 1498
calculating (1497) 1497
computing (1497) 1497
metallurgy (1462) 1462
life sciences & biomedicine (1338) 1338
image data processing or generation, in general (1231) 1231
humans (1114) 1114
basic electronic circuitry (969) 969
decoding (878) 878
coding (876) 876
code conversion in general (875) 875
male (785) 785
female (732) 732
basic electric elements (679) 679
general tagging of cross-sectional technologies spanning over several sections of the ipc (634) 634
general tagging of new technological developments (634) 634
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (634) 634
middle aged (605) 605
human necessities (594) 594
optics (591) 591
aged (537) 537
compositions based thereon (495) 495
organic macromolecular compounds (495) 495
their preparation or chemical working-up (495) 495
heating (466) 466
lighting (464) 464
mechanical engineering (463) 463
blasting (462) 462
weapons (462) 462
layered products (453) 453
layered products, i.e. products built-up of strata of flat ornon-flat, e.g. cellular or honeycomb, form (453) 453
adult (441) 441
devices or arrangements, the optical operation of which ismodified by changing the optical properties of the medium of thedevices or arrangements for the control of the intensity,colour, phase, polarisation or direction of light, e.g.switching, gating, modulating or demodulating (401) 401
frequency-changing (401) 401
non-linear optics (401) 401
optical analogue/digital converters (401) 401
optical logic elements (401) 401
techniques or procedures for the operation thereof (401) 401
semiconductor devices (390) 390
electric solid state devices not otherwise provided for (388) 388
organic chemistry (368) 368
technical subjects covered by former uspc (359) 359
microbiology (350) 350
optical elements, systems, or apparatus (348) 348
information storage (344) 344
information storage based on relative movement between recordcarrier and transducer (338) 338
technical subjects covered by former us classification (328) 328
biochemistry (324) 324
beer (311) 311
enzymology (310) 310
mutation or genetic engineering (310) 310
spirits (310) 310
vinegar (310) 310
wine (310) 310
animals (308) 308
dyes (307) 307
adhesives (306) 306
miscellaneous applications of materials (305) 305
miscellaneous compositions (305) 305
natural resins (305) 305
paints (305) 305
polishes (305) 305
testing (304) 304
measuring (303) 303
vehicles in general (296) 296
surgery (293) 293
technologies or applications for mitigation or adaptation againstclimate change (288) 288
hygiene (282) 282
medical or veterinary science (282) 282
conversion or distribution of electric power (267) 267
generation (267) 267
working of plastics (266) 266
working of substances in a plastic state, in general (266) 266
electric digital data processing (258) 258
oncology (254) 254
agriculture (248) 248
printing (228) 228
forestry (227) 227
lining machines (227) 227
stamps (227) 227
typewriters (227) 227
education (226) 226
culture media (225) 225
compositions thereof (223) 223
fishing (223) 223
microorganisms or enzymes (223) 223
propagating, preserving or maintaining microorganisms (223) 223
trapping (223) 223
animal husbandry (222) 222
hunting (222) 222
after-treatment of the shaped products, e.g. repairing (220) 220
physical sciences (220) 220
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10231) 10231
French (1404) 1404
German (1087) 1087
Japanese (1023) 1023
Chinese (645) 645
Korean (159) 159
Spanish (153) 153
Portuguese (123) 123
Danish (47) 47
Hungarian (17) 17
Slovenian (17) 17
Greek (12) 12
Russian (6) 6
Polish (5) 5
Turkish (5) 5
Indonesian (3) 3
Arabic (2) 2
Croatian (1) 1
Italian (1) 1
Lithuanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


SAE technical paper series, Volume 2011-24-0068.
For better understanding of soot formation and oxidation processes in a diesel spray flame, morphology, microstructure and size of soot particles directly... 
Diesel / Compression Ignition engines | Microscopy | Combustion chambers
eJournal
Journal Article
Journal Article
SAE technical paper series, Volume 2011-01-2046.
For better understanding of soot formation and oxidation processes in a biodiesel spray flame, the morphology, microstructure and sizes of soot particles... 
Particulate matter (PM) | Microscopy | Fuel injection | Biodiesel
eJournal
Journal of hepato-biliary-pancreatic sciences, ISSN 1868-6974, 7/2010, Volume 17, Issue 4, pp. 455 - 462
Journal Article
Journal of hepato-biliary-pancreatic sciences, ISSN 1868-6974, 3/2010, Volume 17, Issue 2, pp. 166 - 173
Journal Article
Annals of surgical oncology, ISSN 1534-4681, 08/2011, Volume 19, Issue 5, pp. 1713 - 1719
Journal Article
Journal of gastroenterology, ISSN 0944-1174, 12/2014, Volume 49, Issue 12, pp. 1524 - 1535
Journal Article
Journal Article
European journal of clinical pharmacology, ISSN 1432-1041, 10/2015, Volume 72, Issue 2, pp. 185 - 193
... Watanabe 8 & Satoshi Yamamoto 9 & Takayuki Hirose 10 & Souich Saitou 11 & Masakatsu Y onezumi 12 & Takeshi Kondo 13 & Yuichi Kato 14 & Noboru Mochizuki 15 & Keiko Ohno... 
Dasatinib | Pharmacodynamics | Biomedicine | Half maximal inhibitory concentration | Phamacokinetics | Pharmacology/Toxicology | Molecular response | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Leukocytes, Mononuclear - metabolism | Antigens, CD34 - metabolism | Oncogene Protein v-crk - antagonists & inhibitors | Humans | Middle Aged | Oncogene Protein v-crk - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Dasatinib - pharmacokinetics | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Phosphorylation - drug effects | Protein Kinase Inhibitors - pharmacokinetics | Leukocytes, Mononuclear - drug effects | Dasatinib - therapeutic use | Treatment Outcome | Dasatinib - pharmacology | Fusion Proteins, bcr-abl - genetics | Protein Kinase Inhibitors - therapeutic use | Fusion Proteins, bcr-abl - antagonists & inhibitors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Aged | Dasatinib - adverse effects | Protein Kinase Inhibitors - pharmacology | Phosphotransferases | Analysis | Chronic myeloid leukemia | Pharmacology | Kinetics | Drug therapy | Leukemia | Chronic illnesses | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 07/2017, Volume 390, Issue 10089, pp. 29 - 39
Summary Background Alectinib, a potent, highly selective, CNS-active inhibitor of anaplastic lymphoma kinase (ALK), showed promising efficacy and tolerability... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Single-Blind Method | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Piperidines - blood | Brain Neoplasms - secondary | Pyridines - adverse effects | Carcinoma, Non-Small-Cell Lung - secondary | Neoplasm Grading | Antineoplastic Agents - adverse effects | Pyrazoles - blood | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Carbazoles - blood | Pyrazoles - adverse effects | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Carbazoles - adverse effects | Lung Neoplasms - enzymology | Kaplan-Meier Estimate | Receptor Protein-Tyrosine Kinases - metabolism | Protein Kinase Inhibitors - blood | Pyridines - blood | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Antineoplastic Agents - blood | Aged | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Medical colleges | Respiratory agents | Care and treatment | Lymphomas | Lung cancer, Non-small cell | Product development | Pharmaceutical industry | Analysis | Toxicity | Funding | Lung cancer | Central nervous system | Metastasis | Kinases | Evidence-based medicine | Recruitment | Motivation | Audio frequencies | Safety | Toxic diseases | Drug dosages | Protein-tyrosine kinase | Effectiveness | Cut-off | Data processing | Group dynamics | Patients | Survival | Lymphoma | Chemotherapy | Inhibitors | Interactive systems | Death | Mutation | Cancer | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article